Stay updated with breaking news from Advanced Solid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Poster Presentations to highlight the ongoing clinical studies targeting Globo H and AKR1C3TAIPEI, Taiwan, May 17, 2022 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174), a leader in First-in-Class Cancer
/PRNewswire/ -- Harbour BioMed (the "Company", HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization...
Presented Updated Clinical Data from Monotherapy Phase 1 Arm of RTX-240 Clinical Trial in Advanced Solid Tumors, Showing Clinical Responses with Favorable Tolerability in PD-1 Refractory Disease ... | May 10, 2022
08.04.2022 - Poster presentation highlights translational work supporting recommended dosing for SRF388 Phase 2 trialsCAMBRIDGE, Mass., April 08, 2022 (GLOBE NEWSWIRE) - Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing ... Seite 1
/PRNewswire/ -- OBI Pharma, a Taiwan biopharma company (TPEx: 4174), today announced that the first patients have been enrolled in both of the Phase 2 studies...